Ceapro Inc V.CZO

Be Afraid

[boazklinghorn]

OK I did watch the thing. It was exactly as predicted. I mean exactly, almost word for word. Until the very end that is. Gilles was even more incomprhensible than usual especially at the end where he talks again about uplisting and making moves on a corporate level to accomplish that goal. He was grinning like a downs kid with an ice cream cone and playing with his own fingers. I am afraid a man who has proven himself incapable of running a company that makes two products and sells them to a single customer has convinced himself he can M and A his way to a Nasdaq listing. How can that go wrong? Judging by the sheer giddiness I would guess we might have some kind of announcment fairly soon.

[ZoranSto]

Thanks Boaz, I have yet to watch it.....but will once it is posted.

[Ciao]

The question about putting a label on products to indicate that AV/BG has been say proven scientifically to promote wound healing was not answered, Gilles only indicated that results can support the claim and mentioned their Juvente line contains both AV/BG already >>> will CRO sell AV/BG to customers who can put on their product labels, "contains ingredients that have been

[boazklinghorn]

It is clear that Gilles is feeling some preasure to perform judging by his repeated statements about completing the PGX scale up in the announced time frame but this presentation was exactly the same as the Dr Ask presentation where an expert tells us in more detail things we already know. There is no concrete plan announced about how to move forward. Imagine if Gilles had taken this opportunity

[Stinzo]

ya its not looking pretty and there is no communiation of any plans ... from my general understanding: -trials are continuously delayed and we are still in very early stages of trials for all of the possible applications  -there is no deal coming  -only hope is building this plant and producing some product and hope that they will be able to sell it to Symrise  this would mean that

[boazklinghorn]

Again lack of any detail from Management. They keep saying that the plant will make YBG but how will it get to market? CZO doesnt have the marketing  expertise (just look at the Juvente debacle) or the cash to create and sell its own brand so again we need a partner who can do that. Siggy are you out there??? Clearly we want tp participate in the final product and not just continue to supply

[ZoranSto]

Well I listened to the presentation and had the same reaction the market did...very little. The presentation was very similar to others in the past. The difference is that in the past we all got excited and the share price rose with that excitment....now the SP does nothing since investors are wanting to see some deals and sales growth....which we are not. Talk and glossy presentations will not

[boazklinghorn]

Last thing today and then I have to actually work. I worry that there are no deal makers anywhere in Ceapros structure. Ronnie is just an administrator  the board is full of academics and Gilles, well Gilles is Gilles. Clearly judging by the 300K spent in Q2 they have somebody advising but that isnt the same as having a real entrepenuer iniciating the deal. I worry if they make a deal it wont

[Alex1726]

As i already said you never get a clear view with that very poor manager but there is one thing i would like to clarify. If i got it right,  the regulator pathway would be as a natural product despite the fact that it was describe as a groundbreaking RESULT BY Dr. Li? A groundbreaking result should incite CZO to choose a pathway that conducts to an approve drug. A grounbreaking result could

[Ciao]

Here's an introductory article; https://www.woundsource.com/blog/how-use-fda-classifications-select-skin-and-wound-care-products This is why you need a partner who specializes in wound healing to accelerate product development. CEAPRO has the ability to produce highly concentrated AV (economically viable). Maybe CEAPRO thinks of royalties for a finished would dressing product vs. selling an

[Hopeforthebest]

Trying to list on the Nasdaq is just another example of how incompetent gagnon as a business executive. If 4 qrtr of negative growth isn't enough, failure to live up to commitments, hiring of incompetent people,sig form example, knowing to allowing wrong formulations for trials, failure to promote company, etc. etc etc., this is the topping on the cake. This week, the last 2 days in